Isoprenaline (C11H17NO3) is an isopropyl analog of epinephrine. It is primarily used to treat asthma, heart block, and various lung related diseases.
This report contains market size and forecasts of Isoprenaline (Isoproterenol) in Global, including the following market information:
Global Isoprenaline (Isoproterenol) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Isoprenaline (Isoproterenol) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Isoprenaline (Isoproterenol) include Sanofi Aventis, HOSPIRA, NEXUS PHARMAACEUTICALS, Amneal Pharmaceuticals, Inc, LGM Pharma, Cipla, Recipharm AB, Triveni Interchem and AMPHASTAR PHARMACEUTICALS and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Isoprenaline (Isoproterenol) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Isoprenaline (Isoproterenol) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Isoprenaline (Isoproterenol) Market Segment Percentages, by Type, 2021 (%)
Injection
Tablets
Others
Global Isoprenaline (Isoproterenol) Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Isoprenaline (Isoproterenol) Market Segment Percentages, by Application, 2021 (%)
Bradycardia
Asthma
Heart Block
Others
Global Isoprenaline (Isoproterenol) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Isoprenaline (Isoproterenol) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Isoprenaline (Isoproterenol) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Isoprenaline (Isoproterenol) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi Aventis
HOSPIRA
NEXUS PHARMAACEUTICALS
Amneal Pharmaceuticals, Inc
LGM Pharma
Cipla
Recipharm AB
Triveni Interchem
AMPHASTAR PHARMACEUTICALS
Biophore